Mary Hatch, PhD [email]
Addictions, Drug & Alcohol Institute
University of Washington
John Roll, PhD [email]
Elson S. Floyd College of Medicine
Washington State University
The Pacific Northwest Node joined the CTN in January 2001 and includes Washington and Northern California. Its CTPs provide a mix of settings including: urban and rural, private and public sector, in-patient/residential and outpatient, and opioid treatment programs. The CTPs provide a wide range of treatment services to nearly 12,000 clients per year. All available services are also targeted to specific groups having special needs such as women, the elderly, Native Americans and Alaska Natives, dual disorder clients, homeless populations, and adolescent clients.
The Pacific Northwest Node is the home of the CTN Dissemination Library.
Grantee Institutions: Addictions, Drug & Alcohol Institute, UW; Washington State University Program of Excellence in the Addictions.
- CTN-0008: Assessment of the National Drug Abuse Clinical Trials Network: A Baseline for Investigating Diffusion of Innovation
- CTN-0012: Characteristics of Screening, Evaluation, and Treatment of HIV/AIDS, Hepatitis C Viral Infections, and Sexually Transmitted Infections in Substance Abuse Treatment Programs
- CTN-0031-A-1: An Evaluation of Neurocognitive Function, Oxidative Damage, and Their Association with Treatment Outcomes in Methamphetamine and Cocaine Abusers
- CTN-0031-A-2: The Role of Alcohol Consumption in Classifications of Alcohol Use Disorders: A Clinical Study
- CTN-0031: Stimulant Abuser Groups to Engage in 12-Step (STAGE-12): Evaluation of a Combined Individual-Group Intervention to Reduce Stimulant and Other Drug Use by Increasing 12-Step Involvement
- CTN-0033-Ot-3: Methamphetamine: Where Does It Fit in the Bigger Picture of Drug Use of American Indian and Alaska Native Communities and Treatment Seekers?
- CTN-0034-Ot: Developing Research Capacity and Culturally Appropriate Research Methods: Community-Based Participatory Research Manual for Collaborative Research in Drug Abuse for American Indians and Alaska Natives
- CTN-0040-S: Pattern of Alcohol Use and Alcohol-Related Diagnoses among Drug Abusing/Dependent Participants
- CTN-0047: Screening Motivational Assessment and Referral to Treatment in Emergency Departments (SMART-ED): Evaluation of Screening, Brief Intervention, Referral to Treatment (SBIRT) and Booster Session for Drug Use Patients Presenting for Treatment in the Emergency Department
- CTN-0051-A-1: Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT) Genetics Study
- CTN-0069-A-1: Retrospective Evaluation of Rapid Buprenorphine Induction in the Emergency Department for Opioid Use Disorder
- CTN-0078-Ot: Knowledge of and Attitudes About Medication Assisted Treatment Within American Indian Communities
- CTN-0080: Medication Treatment for Opioid Use Disorder in Expectant Mothers (MOMs): A Pragmatic Randomized Trial Comparing Two Buprenorphine Formulations (NIH HEAL Initiative)
- CTN-0082-A-1: COVID-19 Vaccine Readiness in People Who Use Substances in Community STI Clinics and Substance Use Intervention or Harm Reduction Programs in Eight Higher HIV Incidence Southeastern Cities
- CTN-0082: Implementation Survey of PrEP and Opioid Use Related Services In STI Clinics and Community Based Organizations (CBOs)
- CTN-0091: Preventing and Identifying Opioid Use Disorder Using the Six Building Blocks (6BBs) for Improving Opioid Prescription Management
- CTN-0106: Derivation and Validation of New Measurement-Based Care Tools Derived from the Brief Addiction Monitor
- CTN-0148: Cocaine Craving and Use Outcomes Secondary Analysis of a Randomized Study to Test the Safety and Effectiveness of Buprenorphine in the Presence of Naltrexone for the Treatment of Cocaine DependenceCTN-0148: